Loading...
Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
INTRODUCTION: The glioblastoma (GBM) immune microenvironment is highly suppressive as it targets and hinders multiple components of the immune system. Checkpoint blockade (CB) is being evaluated for GBM patients. However, biomarker analyses suggest that CB monotherapy may be effective only in a smal...
Saved in:
| Published in: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Impact Journals LLC
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5945499/ https://ncbi.nlm.nih.gov/pubmed/29755681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25061 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|